Seattle Genetics (Nasdaq: SGEN) and Genmab A/S announced that the companies have entered into an additional antibody-drug conjugate (ADC) collaboration ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE